Magic Red® Fluorescent Cathepsin B Assay Kit

Quantitatively monitor intracellular cathepsin B activity over time in vitro. The Magic Red® substrate fluoresces red upon cleavage by active cathepsin enzymes. The signal can be analyzed using fluorescence microscopy or a fluorescence plate reader.



SKU: 937

Size: 25 Tests
Price:
Sale price$206.00

Our Magic Red® Cathepsin assay kits enable researchers to quantitate and monitor intracellular cathepsin B, K, or L activity over time in vitro. The Magic Red® (MR) reagent is a non-cytotoxic substrate that fluoresces red upon cleavage by active cathepsin enzymes.

Elevated cathepsin enzyme activity in serum or the extracellular matrix often signifies a number of gross pathological conditions. Cathepsin-mediated diseases include: Alzheimer’s; numerous types of cancer; autoimmune related diseases like arthritis; and the accelerated breakdown of bone structure seen with osteoporosis. Up-regulated cathepsin B and L activity has been linked to several types of cancer. These include cancer of the colon, pancreas, ovaries, breast, lung, and skin (melanoma). Upregulation of cathepsin K has been shown in lung tumors. Increased cathepsin K activity has also been linked to degenerative bone diseases including osteopetrosis and post-menopausal osteoporosis.

Cathepsins are usually characterized as members of the lysosomal cysteine protease (active site) family and the cathepsin family name has been synonymous with lysosomal proteolytic enzymes. In actuality, the cathepsin family also contains members of the serine protease (cathepsin A and G) and aspartic protease (cathepsin D and E) families as well. These enzymes exist in their processed form as disulfide-linked heavy and light chain subunits with molecular weights ranging from 20-35 kDa. Cathepsin C is the noted exception, existing as an oligomeric enzyme with a MW ~200 kDa. Initially synthesized as inactive zymogens, cathepsins are post-translationally processed into their active configurations after passing through the endoplasmic reticulum and subsequent incorporation into the acidic environment of the lysosomes.

Magic Red® detection substrates utilize the photostable red fluorophore, cresyl violet. When bi-substituted via amide linkage to two cathepsin target peptide sequences, such as (leucine-arginine)2, the bi-substituted cresyl violet is non-fluorescent. Following enzymatic cleavage at one or both arginine (R) amide linkage sites, the mono and non-substituted cresyl violet fluorophores generate red fluorescence when excited at 550-590 nm. Our Magic Red® cathepsin B substrate, MR-(RR)2, is comprised of cresyl violet coupled to two pairs of the amino acid sequence, arginine-arginine (RR), which is the preferential target sequence for cathepsin B. In our cathepsin K substrate, MR-(LR)2, cresyl violet is coupled to two pairs of leucine- arginine (LR). Our MR cathepsin L substrate, MR-(FR)2, contains two pairs of phenylalanine-arginine (FR) coupled to cresyl violet. Cathepsins, like most other crucial cell survival enzymes, are somewhat permissive in the target amino acid sequence they will recognize and cleave. Although Magic Red® substrates contain the amino acid target sequence preferred by a particular cathepsin enzyme, they can also recognize other active cathepsins or proteases when they are present. We encourage validation of cathepsin activity by an orthogonal technique.

To use Magic Red®, add the substrate directly to the cell culture media, incubate, and analyze. Because MR is cell-permeant, it easily penetrates the cell membrane and the membranes of the internal cellular organelles - no lysis or permeabilization steps are required. If cathepsin enzymes are active, they will cleave off the two dipeptide cathepsin targeting sequences and allow the cresyl violet fluorophore to become fluorescent upon excitation. The red fluorescent product will stay inside the cell and will often aggregate inside lysosomes (cathepsins are lysosomal) and other areas of low pH, such as inside the mitochondria. As protease activity progresses and more MR substrate is cleaved, the signal will intensify as the red fluorescent product accumulates within various organelles, enabling researchers to watch the color develop over time and quantify cathepsin B, K, or L activity. By varying the duration and concentration of exposure to the MR substrate, a picture can be obtained of the relative abundance of cathepsin enzymatic activity. Positive cells will fluoresce red and have pronounced red lysosomes and mitochondria. Negative cells will exhibit very low levels of background red fluorescence evenly distributed throughout the cell. This background level of substrate activity could be the result of constitutively synthesized serine proteases that target analogous amino acid sequences for hydrolysis. Please note that Magic Red® substrates can undergo spontaneous hydrolysis over time, resulting in increased background fluorescence. Appropriate controls are necessary for accurate interpretation of the results. There is no interference from pro-cathepsin forms of the enzymes. If the treatment or experimental condition stimulates cathepsin activity, cells containing elevated levels of cathepsin activity will appear brighter red than cells with lower levels of cathepsin activity.

The MR fluorophore, cresyl violet, fluoresces red when excited at 550-590 nm. The red fluorescent signal can be monitored with a fluorescence microscope or plate reader. It has an optimal excitation of 592 nm and emission of 628 nm. Hoechst 33342 is included with the kit to concurrently label nuclei after labeling with MR. It is revealed under a microscope using a UV-filter with excitation at 365 nm and emission at 480 nm. Acridine orange (AO) is also included in the kit to identify lysosomes and other intracellular organelles. It is revealed under a microscope using excitation at 480 nm and emission at >540 nm, or alternatively with excitation at 550 nm and emission at >610 nm.

MR-RR2
Cathepsin B
592 nm / 628 nm
Fluorescence Plate Reader, Fluorescence Microscope
Cell culture
2-8°C
Domestic: Overnight Delivery; International: Priority Shipping
United States
  1. Prepare samples and controls
  2. Reconstitute Magic Red by adding DMSO.
  3. Dilute Magic Red 1:10 by adding diH2O.
  4. Add 20 µL Magic Red to each sample (~ 500 µL aliquot of cultured cells).
  5. Incubate while protected from light.
  6. Watch color start to develop within 15 minutes.
  7. If desired, label with additional stains, such as Hoechst, DAPI, or an antibody.
  8. If desired, fix cells.
  9. Analyze with a fluorescence microscope or fluorescence plate reader. Magic Red has an optimal excitation at 592 nm and emission at 628 nm.

If working with adherent cells, please see the manual for additional protocols.

Kit 937: 25 Tests
  • Magic Red Substrate (MR-RR2), 1 25 Test Vial, #6133
  • Hoechst 33342, 1 mL, #639
  • Acridine Orange, 0.5 mL, #6130
  • Kit Manual
  • Kit 938: 100 Tests
  • Magic Red Substrate (MR-RR2), 1 100 Test Vial, #6134
  • Hoechst 33342, 1 mL, #639
  • Acridine Orange, 0.5 mL, #6130
  • Kit Manual
  • Product Specific References

    PMID Publication
    38130933Lee, J., et al. 2023. Particulate matter 10 induces oxidative stress and apoptosis in rhesus macaques skin fibroblast. PeerJ, e16589.
    37936170Wu, A.Y., et al. 2023. Spatiotemporal roles of AMPK in PARP-1- and autophagy-dependent retinal pigment epithelial cell death caused by UVA. Journal of biomedical science, 91.
    37981210Kim, Y., et al. 2023. A Surge of Cytosolic Calcium Dysregulates Lysosomal Function and Impairs Autophagy Flux during Cupric Chloride-Induced Neuronal Death. The Journal of biological chemistry, 105479.
    38009916Wang, Z., et al. 2023. The role of lysosomes as intermediates in betacoronavirus PHEV egress from nerve cells. Journal of virology, e0133823.
    37741453Quan, J.H., et al. 2023. Toxoplasma gondii induces pyroptosis in human placental trophoblast and amniotic cells by inducing ROS production and activation of cathepsin B and NLRP1/NLRP3/NLRC4/AIM2 inflammasome. The American journal of pathology, 00362-0.
    36707427Serra-Vinardell, J., et al. 2023. LYST deficiency impairs autophagic lysosome reformation in neurons and alters lysosome number and size. Cellular and molecular life sciences : CMLS, 53.
    36746928Marchand, B., et al. 2023. Gemcitabine promotes autophagy and lysosomal function through ERK- and TFEB-dependent mechanisms. Cell death discovery, 45.
    36814381Mahmood, A., et al. 2023. Exosome secretion kinetics are controlled by temperature. Biophysical journal.
    36914626Rowland, L.A., et al. 2023. De novo lipogenesis fuels adipocyte autophagosome and lysosome membrane dynamics. Nature communications, 1362.
    37098348Wang, Z., et al. 2023. Cellular proteins act as surfactants to control the interfacial behavior and function of biological condensates. Developmental cell.
    37056248Chaiamarit, T., et al. 2023. Fluorescence Assays for Real-Time Tracking of Cell Surface Protein Internalization and Endosomal Sorting in Axons of Primary Mouse Hippocampal Neurons. Bio-protocol, e4651.
    37213076Shelke, G.V., et al. 2023. Inhibition of endolysosome fusion increases exosome secretion. The Journal of cell biology.
    37269887Bellese, G., et al. 2023. Neratinib is a TFEB and TFE3 activator that potentiates autophagy and unbalances energy metabolism in ERBB2+ breast cancer cells. Biochemical pharmacology, 115633.
    37279824Tobias, T., et al. 2023. In vitro immune and redox response induced by cationic cellulose-based nanomaterials.. Toxicology in Vitro, 105616.
    37390818Zhang, J., et al. 2023. Lysosomal LAMP proteins regulate lysosomal pH by direct inhibition of the TMEM175 channel. Molecular cell.
    37284455An, J., et al. 2023. Nicotine exacerbates atherosclerosis and plaque instability via NLRP3 inflammasome activation in vascular smooth muscle cells. Theranostics, 2825-2842.
    37211762Wang, Y., et al. 2023. Polyphyllin D punctures hypertrophic lysosomes to reverse drug resistance of hepatocellular carcinoma by targeting acid sphingomyelinase. Molecular therapy : the journal of the American Society of Gene Therapy.
    37375535Zhang, C., et al. 2023. Bis-Benzylisoquinoline Alkaloids Inhibit Porcine Epidemic Diarrhea Virus by Disrupting Virus Entry. Pathogens (Basel, Switzerland).
    37416869Alhaider, A., et al. 2023. Insulin-like growth factor-1 improves in vitro meiotic resumption of dromedary camel (Camelus Dromedarius) oocytes. Animal Reproduction, e20220105.
    37452023Berquez, M., et al. 2023. Lysosomal cystine export regulates mTORC1 signaling to guide kidney epithelial cell fate specialization. Nature communications, 3994.
    37625588Noda, K., et al. 2023. Characterization of Rab32- and Rab38-positive lysosome-related organelles in osteoclasts and macrophages. The Journal of biological chemistry, 105191.
    35194165Wu, CI., et al. 2022. APP and DYRK1A regulate axonal and synaptic vesicle protein networks and mediate Alzheimer's pathology in trisomy 21 neurons. Molecular psychiatry.
    35121108Capuozzo, A., et al. 2022. Fluoxetine ameliorates mucopolysaccharidosis type IIIA. Molecular therapy : the journal of the American Society of Gene Therapy.
    35222364Santos, S.A.C.S., et al. 2022. P2X7 Receptor Triggers Lysosomal Leakage Through Calcium Mobilization in a Mechanism Dependent on Pannexin-1 Hemichannels. Frontiers in Immunology, 752105.
    35319746Murakawa, T., et al. 2022. A Drosophila toolkit for HA-tagged proteins unveils a block in autophagy flux in the last instar larval fat body. Development (Cambridge, England).
    35309917Vargas, G., et al. 2022. Negative Modulation of Macroautophagy by Stabilized HERPUD1 is Counteracted by an Increased ER-Lysosomal Network With Impact in Drug-Induced Stress Cell Survival. Frontiers in cell and developmental biology, 743287.
    35269509Huang, P., et al. 2022. Lysosomal ATP Transporter SLC17A9 Controls Cell Viability via Regulating Cathepsin D. Cells.
    36186127Lin, X., et al. 2022. Folic acid Ameliorates the Declining Quality of Sodium Fluoride-Exposed Mouse Oocytes through the Sirt1/Sod2 Pathway. Aging and Disease.
    35435672Li, Y., et al. 2022. Tumor Microenvironment-Responsive Yolk-Shell NaCl@Virus-Inspired Tetrasulfide-Organosilica for Ion-Interference Therapy via Osmolarity Surge and Oxidative Stress Amplification. ACS nano.
    35489582Wooten, J., et al. 2022. Dibenzyl trisulfide induces caspase-independent death and lysosomal membrane permeabilization of triple-negative breast cancer cells. Fitoterapia, 105203.
    35599014Zhong, W., et al. 2022. Defective mitophagy in aged macrophages promotes mitochondrial DNA cytosolic leakage to activate STING signaling during liver sterile inflammation. Aging cell, e13622.
    35750034Hu, M., et al. 2022. Parkinson's disease-risk protein TMEM175 is a proton-activated proton channel in lysosomes. Cell, 2292-2308.e20.
    37396505Tanno, T., et al. 2022. A novel aptamer-based small RNA delivery platform and its application to cancer therapy. Genes & Diseases.
    35771772Oe, Y., et al. 2022. PACSIN1 is indispensable for amphisome-lysosome fusion during basal autophagy and subsets of selective autophagy. PLoS genetics, e1010264.
    35977928Ratto, E., et al. 2022. Direct control of lysosomal catabolic activity by mTORC1 through regulation of V-ATPase assembly. Nature communications, 4848.
    36044857Akter, E., et al. 2022. Non-degradable autophagic vacuoles are indispensable for cell competition. Cell reports, 111292.
    36055242Fernandez, M.A., et al. 2022. Loss of endosomal exchanger NHE6 leads to pathological changes in tau in human neurons. Stem cell reports.
    36044568Iyer, H., et al. 2022. A lysosomal regulatory circuit essential for the development and function of microglia. Science advances, eabp8321.
    36195598Hao, W., et al. 2022. Autophagy induction promoted by m6A reader YTHDF3 through translation upregulation of FOXO3 mRNA. Nature communications, 5845.
    36180832Li, Y., et al. 2022. Inhibition of CISD2 promotes ferroptosis through ferritinophagy-mediated ferritin turnover and regulation of p62-Keap1-NRF2 pathway. Cellular & molecular biology letters, 81.
    36197338Hiragi, S., et al. 2022. TBC1D18 is a Rab5-GAP that coordinates endosome maturation together with Mon1. The Journal of cell biology.
    36512240Mulligan, R.J., et al. 2022. Endosomal Transport to Lysosomes and the Trans-Golgi Network in Neurons and Other Cells: Visualizing Maturational Flux. Methods in molecular biology (Clifton, N.J.), 595-618.
    33414397Zhao, T., et al. 2021. Autophagy impairment as a key feature for acetaminophen-induced ototoxicity. Cell death & disease, 3.
    33502918Browning, C.L., et al. 2021. Manganese dioxide nanosheets induce mitochondrial toxicity in fish gill epithelial cells. Nanotoxicology, 44944.
    33386512Honma, Y., et al. 2021. Correlation of hepatitis C virus-mediated endoplasmic reticulum stress with autophagic flux impairment and hepatocarcinogenesis. Medical molecular morphology.
    33422265Miao, G., et al. 2020. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation. Developmental cell.

    Question: When you dilute the stock concentration 1/10 in H2O and aliquot is for future use, how long can this be stored? I see that the stock concentration in DMSO can be stored for 6 months.

    Answer: Once the stock solution is diluted 1:10 in diH2O we recommend using within 15 minutes to prevent hydrolysis of the Magic Red substrate. Non-specific hydrolysis would lead to fluorescence not associated with enzymatic cleavage of the substrate. We do not recommend attempting to aliquot or store the diH2O-diluted substrate solution for future use. Yes, that’s correct. The DMSO-reconstituted Magic Red stock can be stored frozen for up to 6 months protected from light and thawed more than twice during that time.

    Bulk Order Magic Red® Fluorescent Cathepsin B Assay Kit

    Related Products

    Recently viewed